01 / COMPOSITION
Active Ingredient & Assay
Each tablet contains Phenobarbitone IP 60 mg formulated with pharmaceutical-grade excipients, adhering to stringent Pharmacopoeial limits for assay, dissolution, and content uniformity.
Blessme · Neuro Products
Phenobarbitone Tablets - BARZOX-60 (60 mg)
BARZOX-60 is a Phenobarbitone Tablet IP 60 mg formulation by Blessme, the neurology division of Dellwich Lifescience LLP. Manufactured under applicable quality standards, it offers verified product specifications for professional pharmaceutical requirements. Available for eligible PCD franchise, third-party manufacturing, and hospital supply enquiries.
WHO-GMP Certified
Schedule H Prescription
Pan-India Dispatch
Product SpecificationsAbout Phenobarbitone 60 mg
About Phenobarbitone 60 mg
(BARZOX-60)
Detailed technical data, active pharmaceutical ingredient specifications, dosage format, and regulatory classification for BARZOX-60.
Blessme · Neuro Products
Phenobarbitone 60 mg - BARZOX-60
Phenobarbitone Tablets IP 60 mg is an anticonvulsant medicine used in the management of certain seizure disorders under medical supervision.
Management of Generalized Tonic-Clonic Seizures Management of Partial-Onset Seizures Control of Certain Epileptic Seizure Disorders Use Under Qualified Medical Supervision
- Product Brand Name
- BARZOX-60
- Active Pharmaceutical Ingredient
- Phenobarbitone IP (60 mg)Verified
- Therapeutic Class
- Anti Convulsant / Anti Epileptic
- Dosage Form
- Oral Solid Tablet
- Strength
- 60 mg per tablet
- Standard Packaging
- 20 x 10 Blister Pack (200 Tablets Box)
- Regulatory Category
- Narcotic Drug
- Marketing Division
- Blessme · Neuro & Psychiatric Products
- Marketing & Distribution Company
- Dellwich Lifescience LLP, Ahmedabad, Gujarat
- Storage Condition
- Store protected from light and moisture at below 30°C
- Quality Standard
- Manufactured in WHO-GMP & ISO 9001:2015 Certified Units
- Country of Origin
- India
Phenobarbitone Tablet 60 mg GuidePhenobarbitone Tablet 60 mg & BARZOX-60
Phenobarbitone Tablet 60 mg & BARZOX-60
Complete Medical & Commercial Guide
Everything you need to know about Phenobarbitone Tablets IP 60 mg, marketed as BARZOX-60 by Blessme Neuro Products (Dellwich Lifescience LLP). Covers uses, dosage, mechanism, brands, pricing, and supply across India.
What is Phenobarbitone Tablet?
Phenobarbitone tablet is a barbiturate-class anticonvulsant and anti-epileptic medicine. The active ingredient, Phenobarbitone IP, acts on the central nervous system to control seizure activity. Phenobarbitone Tablets IP 60 mg (BARZOX-60) is a higher-strength formulation manufactured by Blessme division of Dellwich Lifescience LLP under WHO-GMP certified conditions.
When people search for Phenobarbitone tablet, Phenobarbitone tablets IP, or Phenobarbitone 60 mg tablet, they are typically looking for a verified, pharmacy-grade anticonvulsant. BARZOX-60 answers that need with a consistent 60 mg strength per tablet.
Phenobarbitone Tablet Uses & Indications
Phenobarbitone tablet uses span several neurological conditions. BARZOX-60 (Phenobarbitone Tablets IP 60 mg) is indicated for:
- Generalized tonic-clonic seizures (grand mal epilepsy) - long-term prophylaxis.
- Partial / focal seizures - monotherapy or adjunctive therapy.
- Status epilepticus maintenance - post-acute stabilization.
- Neonatal seizure protocols - under pediatric neurology supervision.
- Sedation & pre-anesthetic medication - in controlled clinical settings.
These Phenobarbitone tablet uses make it a staple in neurology practice across India, and BARZOX-60 offers a dependable 60 mg option for clinicians and hospitals.
How Phenobarbitone Tablets Work (Mechanism of Action)
Phenobarbitone tablets bind allosterically to GABAA receptors in the central nervous system. This enhances GABA-mediated chloride influx, hyperpolarizes post-synaptic neuronal membranes, raises the seizure threshold, and dampens the propagation of abnormal epileptogenic discharges. In simpler terms, Phenobarbitone 60 mg calms overactive electrical activity in the brain that causes seizures.
Phenobarbitone Tablet Dosage & Strength
BARZOX-60 contains Phenobarbitone IP 60 mg per tablet. Dosage is individualized by a registered medical practitioner based on age, weight, seizure type, and response to therapy. It is a Schedule H prescription drug and must be taken strictly as directed.
- Form: Oral solid tablet
- Strength: 60 mg per tablet
- Packaging: 20 x 10 blister pack (200 tablets per box)
- Storage: Protected from light & moisture, below 30°C
- Prescription: Schedule H - valid prescription required
Phenobarbitone Tablet Brands in India
Several phenobarbitone tablet brands exist in India. BARZOX-60 by Blessme (Dellwich Lifescience LLP) distinguishes itself through WHO-GMP & ISO 9001:2015 manufacturing, high-barrier blister packaging, and dedicated B2B / PCD franchise support across Gujarat and India.
When comparing Phenobarbitone tablet brands in India, look for Pharmacopoeial purity, stable 60 mg assay, tamper-evident blister strips, and available Certificates of Analysis (COA) - all of which BARZOX-60 provides.
Important Safety Information - Phenobarbitone 60 mg
Phenobarbitone is a potent CNS depressant. Risks include sedation, tolerance, dependence, and drug-drug interactions (it induces cytochrome P450 enzymes). Do not stop abruptly without medical guidance - rebound seizures may occur. Supplied strictly against a valid prescription and drug licence.
Quality & Production
Quality assurance and compliance
BARZOX-60 is manufactured under controlled pharmaceutical production processes, focusing on batch-to-batch consistency, quality assurance, and compliance with applicable manufacturing standards.
02 / PACKAGING
High-Barrier Blister Pack
Packaged in tamper-evident Alu-PVC blister strips that safeguard against ambient moisture, temperature variations, and photodegradation during transportation and storage.
03 / DOCUMENTATION
COA & Batch Records
Complete technical dossier, Certificate of Analysis (COA), Material Safety Data Sheet (MSDS), and stability data are readily furnished for hospital procurement and institutional audits.
04 / COMPLIANCE
WHO-GMP & Schedule M
Manufactured in accredited WHO-GMP and Schedule M certified facilities following Good Laboratory Practices (GLP) and validated automated compression and blister packaging.
Clinical Profile & Precautions
Approved Indications & Safety Guidelines
As a Schedule H barbiturate-class medication, Phenobarbitone requires responsible administration and strict adherence to registered medical prescription guidelines.
Prescription-Only Schedule H Medication Notice
Phenobarbitone is a potent central nervous system depressant and anticonvulsant. It carries potential risks of sedation, tolerance, dependence, and significant drug-drug interactions. It must strictly be administered under the direction of a licensed neurologist or physician. Do not abruptly cease therapy without medical guidance to avoid rebound seizures.
Clinical Indications
Phenobarbitone 60 mg (BARZOX-60) is indicated in evidence-based neurological practice for:
- Generalized Tonic-Clonic Seizures: Long-term prophylaxis and control of grand mal epilepsy.
- Partial / Focal Seizures: Effective as monotherapy or adjunctive therapy in complex partial seizures.
- Status Epilepticus Maintenance: Post-acute stabilization following acute emergency anticonvulsant protocols.
- Neonatal Seizure Protocols: Under specialized pediatric neurology supervision.
Pharmacology & Precautions
Pharmacological parameters and essential monitoring protocols for healthcare practitioners:
- Mechanism of Action: Allosteric modulation of GABAA receptors, prolonging chloride ionophore open time and raising the seizure threshold.
- Contraindications: Severe respiratory depression, acute intermittent porphyria, and known barbiturate hypersensitivity.
- Hepatic / Renal Care: Regular monitoring of liver and kidney function advised during prolonged therapy.
- Drug Interactions: Induces cytochrome P450 hepatic enzymes, which may reduce the efficacy of oral contraceptives, warfarin, and other co-administered agents.
Manufacturing & Marketing
Dellwich Lifescience LLPBlessme · Neuro & Psychiatric Division
About Dellwich Lifescience
Trusted Neuro Pharmaceutical Manufacturer in Ahmedabad, Gujarat
Dellwich Lifescience LLP is a pharmaceutical company based in Ahmedabad, Gujarat, focused on pharmaceutical manufacturing, quality assurance, and product distribution. Through our specialized neurology division, Blessme, we offer neuro and psychiatry pharmaceutical products, including BARZOX-60 (Phenobarbitone Tablets IP 60 mg).
We support eligible PCD pharma franchise partners, pharmaceutical distributors, and institutional supply enquiries across India, with an emphasis on reliable distribution and consistent product quality.
Commercial PartnershipsBARZOX-60 Supply &
BARZOX-60 Supply &
Pharmaceutical Distribution
Whether you are seeking BARZOX-60 (Phenobarbitone Tablets IP 60 mg) for eligible PCD pharma franchise opportunities, third-party pharmaceutical manufacturing, or institutional hospital supply, Dellwich Lifescience LLP supports professional supply enquiries with a focus on product quality, reliable distribution, and dependable pharmaceutical supply solutions.
Monopoly PCD Franchise
Secure exclusive territory rights for BARZOX-60 and the entire Blessme Neuro range with visual aids, MR bags, LBLs, catch covers, and aggressive margin support.
Third-Party Manufacturing
Contract manufacturing solutions for neurology brands with customizable batch sizes, fast turnaround, stringent QA/QC batch testing, and regulatory documentation.
Hospital & Institutional Supply
Direct bulk procurement partnerships for private hospitals, neurology clinics, psychiatric institutes, and government medical tenders with pan-India cold-chain logistics.
Common Questions
Frequently Asked Questions about BARZOX-60
Verified answers to common clinical, commercial, and regulatory queries regarding Phenobarbitone 60 mg tablets.
What is Phenobarbitone tablet and what is BARZOX-60?
Phenobarbitone tablet (marketed under the brand name BARZOX-60 by Blessme, Dellwich Lifescience LLP) is an established barbiturate-class anticonvulsant and anti-epileptic medicine. Each tablet contains Phenobarbitone IP 60 mg for the clinical management of seizures.
What are the primary clinical uses and indications of Phenobarbitone tablets?
Phenobarbitone tablets (BARZOX-60) are clinically indicated for the prevention and treatment of generalized tonic-clonic (grand mal) seizures, partial seizures (focal epilepsy), status epilepticus maintenance, and specific neonatal seizure protocols under neurologist supervision.
How do Phenobarbitone tablets work in the central nervous system?
Phenobarbitone tablets act by binding allosterically to GABAA receptors in the central nervous system. This enhances GABA-mediated chloride influx, hyperpolarizes post-synaptic neuronal membranes, raises seizure thresholds, and dampens the propagation of abnormal epileptogenic discharges.
Can BARZOX-60 be purchased over-the-counter without a doctor's prescription?
No. BARZOX-60 contains Phenobarbitone, which is classified as a Schedule H / prescription barbiturate drug in India. It must be dispensed exclusively against a valid prescription from a registered medical practitioner.
What packaging and strip configurations are available for BARZOX-60?
BARZOX-60 is packaged in high-barrier 20 x 10 tablet blister packs designed to protect the formulation from ambient moisture and light. Custom packaging configurations are available for hospital supply and bulk distribution.
Who manufactures and markets BARZOX-60 in Ahmedabad, India?
BARZOX-60 is marketed and distributed by Dellwich Lifescience LLP, headquartered in Science City, Ahmedabad, Gujarat, under its dedicated neurology and psychiatry portfolio 'Blessme Neuro Products'.
Is PCD pharma franchise available for BARZOX-60 and Blessme Neuro products?
Yes. Dellwich Lifescience LLP provides exclusive monopoly-based PCD pharma franchise opportunities for the entire Blessme Neuro and Psychiatric range, including BARZOX-60, backed by comprehensive marketing materials and promotional support.
How can hospitals and distributors place bulk orders for BARZOX-60?
Hospitals, government procurement bodies, wholesalers, and licensed pharma distributors can contact Dellwich Lifescience LLP by calling +91-9909931992 or emailing [email protected] to obtain commercial quotes, Certificates of Analysis (COA), and dispatch schedules.
What is the difference between Phenobarbitone tablet 30 mg and 60 mg?
Phenobarbitone tablets are available in different strengths. BARZOX-30 contains Phenobarbitone IP 30 mg per tablet, while BARZOX-60 contains Phenobarbitone IP 60 mg per tablet. The appropriate strength is determined by the treating neurologist based on seizure type, patient response, and clinical need.
What are the side effects of Phenobarbitone 60 mg tablet?
Phenobarbitone 60 mg may cause sedation, dizziness, drowsiness, nausea, and in some cases tolerance or dependence with long-term use. Serious effects such as respiratory depression require immediate medical attention. Always use under a registered medical practitioner's supervision.
What is the price of Phenobarbitone 60 mg tablet in India?
Phenobarbitone 60 mg tablet price varies by vendor, quantity, and region. For accurate BARZOX-60 pricing, bulk quotes, and MOQ details, contact Dellwich Lifescience LLP at +91-9909931992 or [email protected].
Can I buy Phenobarbitone 60 mg tablet online without a prescription?
No. Phenobarbitone is a Schedule H prescription drug in India. BARZOX-60 is supplied strictly against a valid prescription from a registered medical practitioner and appropriate drug licence.
Is BARZOX-60 available for PCD pharma franchise?
Yes. Dellwich Lifescience LLP offers monopoly-based PCD pharma franchise rights for BARZOX-60 and the full Blessme Neuro range, including promotional materials, visual aids, and margin support for designated districts across India.
Where is BARZOX-60 manufactured?
BARZOX-60 is manufactured by Dellwich Lifescience LLP in WHO-GMP and ISO 9001:2015 certified facilities located in Ahmedabad, Gujarat, India, under the Blessme Neuro Products division.
Does BARZOX-60 come with a Certificate of Analysis (COA)?
Yes. Dellwich Lifescience LLP provides Certificates of Analysis (COA), batch records, MSDS, and stability data for BARZOX-60 to support hospital procurement, tenders, and institutional audits.
Direct Pharmaceutical Enquiry
Need Verified Information or Bulk Supply of BARZOX-60?
Connect directly with Dellwich Lifescience LLP for commercial quotes, monopoly PCD distributorship availability, Certificates of Analysis (COA), or third-party manufacturing specifications.
Direct Manufacturer Pricing & Transparent MOQ
Exclusive PCD Monopoly Rights for Designated Districts
Fast Dispatch from Ahmedabad with GST Invoicing
Comprehensive Marketing, Visual Aids & Promotional Inputs
Quick Assistance & Orders
Enquire About BARZOX-60
Get bulk pricing, PCD monopoly availability, and technical documentation for Phenobarbitone 60 mg.
Blessme · BARZOX-60
Why Choose BARZOX-60 (Phenobarbitone 60 mg)?
When sourcing Phenobarbitone tablets IP or a reliableBARZOX tablet supplier, BARZOX-60 by Blessme delivers verified quality, transparent pricing, and pan-India B2B support.
WHO-GMP Certified Quality
BARZOX-60 is manufactured in WHO-GMP and ISO 9001:2015 certified units, ensuring consistent Phenobarbitone IP 60 mg assay batch after batch.
High-Barrier Blister Packaging
Tamper-evident Alu-PVC 20 x 10 strips protect the 60 mg formulation from moisture, light, and temperature variation during transit and storage.
Pan-India Dispatch from Ahmedabad
Direct bulk supply from Science City, Ahmedabad with GST invoicing, COA documentation, and reliable delivery to hospitals and distributors nationwide.
PCD Monopoly Franchise Rights
Exclusive territory-based PCD pharma franchise for BARZOX-60 and the Blessme Neuro range, with visual aids, MR bags, and promotional support.
Full Regulatory Documentation
COA, MSDS, batch records, and stability data readily furnished for hospital tenders, government procurement, and institutional audits.
Direct Manufacturer Support
Speak directly with Dellwich Lifescience LLP for commercial quotes, technical specifications, and custom packaging requirements for BARZOX-60.